| Dr Joel B Hellman, MD | |
|
1340 Charles St, Suite 300, Rockford, IL 61104-2200 | |
| (779) 696-5888 | |
| Not Available |
| Full Name | Dr Joel B Hellman |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Interventional Cardiology |
| Location | 1340 Charles St, Rockford, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568402451 | NPI | - | NPPES |
| 05732097 | Other | IL | BCBS GROUP NUMBER |
| 036089039-3 | Medicaid | IL | |
| 108259 | Other | IL | HEALTH ALLIANCE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 36059853 (Illinois) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | 036-059853 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joel B Hellman, MD Po Box 1567, Rockford, IL 61110-0067 Ph: () - | Dr Joel B Hellman, MD 1340 Charles St, Suite 300, Rockford, IL 61104-2200 Ph: (779) 696-5888 |
News Archive
New modelling predicts the prevalence of obesity and severe obesity among Australian adults will significantly increase by 2025, as part of a wider research project examining the most effective ways to combat obesity.
A post on the Global Health Technologies Coalition's (GHTC) "Breakthroughs" blog describes an event to launch a recent report from GHTC and Policy Cures on "data on U.S. investments over the past 10 years in global health research and development (R&D)."
A new study by the Department of Clinical Bioethics at the National Institutes of Health, has found that twice as many cancer patients testing medications in early, phase 1 clinical trials have positive response rates than had been previously believed.
Cell Therapeutics, Inc. (CTI) announced today that it concluded an agreement with the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) in Germany for PIXUVRI® (pixantrone).
BioLineRx, a biopharmaceutical development company, announced today that it has filed the necessary regulatory submissions to commence a Phase 1/2 trial for BL-7010 - for the treatment of celiac disease - with the Finnish National Supervisory Authority for Welfare and Health (Valvira). The relevant ethics committee has already approved commencement of the study.
› Verified 2 days ago
Dr. Adekola Abioudun Ashaye, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 W State St, Rockford, IL 61102 Phone: 815-490-1600 Fax: 815-490-1881 | |
Prasad K. Kilaru, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2350 N Rockton Ave, Rockford, IL 61103 Phone: 815-971-2000 | |
David R. Mitchell, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 5970 Churchview Dr, Rockford, IL 61107 Phone: 815-971-2000 | |
Dr. Amrutha Mary George, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1253 N Alpine Rd, Rockford, IL 61107 Phone: 779-696-9201 | |
Rajyalaxmi Mullapudi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5666 E State St, Rockford, IL 61108 Phone: 815-226-2000 | |
Geoffrey Tsaras, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1340 Charles St Ste 404, Rockford, IL 61104 Phone: 779-696-1890 Fax: 779-696-2410 | |
Stephanie Birmingham, APN Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2400 N Rockton Ave, Rockford, IL 61103 Phone: 815-971-5000 |